MEI Pharma Inc./$MEIP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MEI Pharma Inc.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
Ticker
$MEIP
Sector
Primary listing
Employees
28
Headquarters
Website
MEI Pharma Inc. Metrics
BasicAdvanced
$158M
-
-$4.75
-0.01
-
Price and volume
Market cap
$158M
Beta
-0.01
52-week high
$9.00
52-week low
$1.46
Average daily volume
2.2M
Financial strength
Current ratio
16.784
Quick ratio
16.536
Profitability
EBITDA (TTM)
-16.609
Management effectiveness
Return on assets (TTM)
-23.23%
Return on equity (TTM)
-89.74%
Valuation
Price to book
1.67
Price to tangible book (TTM)
1.67
Price to free cash flow (TTM)
-0.896
Free cash flow yield (TTM)
-111.66%
Free cash flow per share (TTM)
-5.46
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
-221.06%
3-year earnings per share growth (CAGR)
-22.91%
10-year earnings per share growth (CAGR)
-16.38%
MEI Pharma Inc. News
AllArticlesVideos
BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode
TheNewswire·4 weeks ago
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange
Business Wire·4 weeks ago
Why Is MEI Pharma Stock Soaring On Friday?
Benzinga·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MEI Pharma Inc. stock?
MEI Pharma Inc. (MEIP) has a market cap of $158M as of August 18, 2025.
What is the P/E ratio for MEI Pharma Inc. stock?
The price to earnings (P/E) ratio for MEI Pharma Inc. (MEIP) stock is 0 as of August 18, 2025.
Does MEI Pharma Inc. stock pay dividends?
No, MEI Pharma Inc. (MEIP) stock does not pay dividends to its shareholders as of August 18, 2025.
When is the next MEI Pharma Inc. dividend payment date?
MEI Pharma Inc. (MEIP) stock does not pay dividends to its shareholders.
What is the beta indicator for MEI Pharma Inc.?
MEI Pharma Inc. (MEIP) has a beta rating of -0.01. This means that it has an inverse relation to market volatility.